The impact of oral antiplatelet responsiveness on the long-term prognosis after coronary stenting

American Heart Journal

Volumn 154, Issue 4, 2007, Pages 676-681

  Foussas, Stefanos G ^a   Zairis, Michael N ^a   Patsourakos, Nikolaos G ^a   Makrygiannis, Stamatis S ^a   Adamopoulou, Evdokia N ^a   Handanis, Stylianos M ^a   Prekates, Athanasios A ^a   Fakiolas, Constantine N ^a   Pissimissis, Evangelos G ^a   Olympios, Christopher D ^a   Argyrakis, Spyros K ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; COLLAGEN;

ADULT; ANALYZER; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG RESPONSE; FEMALE; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONSURGICAL INVASIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY;

AGED; ASPIRIN; CORONARY ANGIOGRAPHY; CREATINE KINASE, MB FORM; DRUG THERAPY, COMBINATION; DRUG TOLERANCE; FEMALE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; STENTS; TICLOPIDINE;

EID: 34548772475     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.06.013     Document Type: Article

References (13)

1. Steinhubl S.R., Ellis S.G., Wolski K., et al. Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. Circulation 103 (2001) 1403-1409
2. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
3. Steinhubl S.R., Berger P.B., and Mann III J.T. Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (2002) 2411-2420
4. Grotemeyer K.H., Scharafinski H.W., and Husstedt I.W. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 71 (1993) 397-403
5. Eikelboom J.W., Hirsh J., Weitz J.I., et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105 (2002) 1650-1655
6. Gum P.A., Kottke-Marchant K., Poggio E.D., et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88 (2001) 230-235
7. Gum P.A., Kottke-Marchant K., Welsh P.A., et al. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 41 (2003) 961-965
8. Lev E.I., Patel R.T., Maresh K.J., et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol 47 (2006) 27-33
9. Chen W.H., Lee P.Y., Ng W., et al. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43 (2004) 1122-1126
10. Gianetti J., Parri M.S., Sbrana S., et al. Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study. Thromb Res 118 (2006) 487-493
11. Borna C., Lazarowski E., van Heusden C., et al. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 3 (2005) 10
12. Fuchs I., Frossard M., Spiel A., et al. Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. J Thromb Haemost 4 (2006) 2547-2552
13. Haubelt H., Anders C., Vogt A., et al. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals. Br J Haematol 130 (2005) 759-767